Literature DB >> 19390556

Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation.

Alexander F Jeans1, Ian Frayling, Bharat Jasani, Lucy Side, Claire Blesing, Olaf Ansorge.   

Abstract

BACKGROUND: A 37-year-old woman presented with a supratentorial cerebral mass, which was diagnosed histologically as a primitive neuroectodermal tumor. She had been treated for rectal adenocarcinoma 7 years previously. A family history revealed a young-onset colorectal carcinoma in the patient's father. INVESTIGATIONS: Immunohistochemical analysis for DNA mismatch repair proteins, germline mutation analysis of MSH2. DIAGNOSIS: Lynch syndrome with a heterozygous germline mutation in MSH2. MANAGEMENT: Debulking of the cerebral tumor, craniospinal axis radiotherapy, and genetic counseling of family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390556     DOI: 10.1038/nrclinonc.2009.35

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  13 in total

1.  Supratentorial primitive neuroectodermal tumor (sPNET).

Authors:  Peter C Burger
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

2.  Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations.

Authors:  Richard H Scott; Sahar Mansour; Kathryn Pritchard-Jones; Devinder Kumar; Fergus MacSweeney; Nazneen Rahman
Journal:  Nat Clin Pract Oncol       Date:  2007-02

3.  PMS2 mutations in childhood cancer.

Authors:  Michel De Vos; Bruce E Hayward; Ruth Charlton; Graham R Taylor; Adam W Glaser; Susan Picton; Trevor R Cole; Eamonn R Maher; Carole M E McKeown; Jill R Mann; John R Yates; Diana Baralle; Julia Rankin; David T Bonthron; Eamonn Sheridan
Journal:  J Natl Cancer Inst       Date:  2006-03-01       Impact factor: 13.506

4.  Survival of patients with Turcot's syndrome and glioblastoma.

Authors:  A Merlo; C Rochlitz; R Scott
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

5.  Recurrent germline mutation in MSH2 arises frequently de novo.

Authors:  D C Desai; J C Lockman; R B Chadwick; X Gao; A Percesepe; D G Evans; M Miyaki; S T Yuen; P Radice; E R Maher; F A Wright; A de La Chapelle
Journal:  J Med Genet       Date:  2000-09       Impact factor: 6.318

6.  Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.

Authors:  S Y Leung; S T Yuen; T L Chan; A S Chan; J W Ho; K Kwan; Y W Fan; K N Hung; L P Chung; A H Wyllie
Journal:  Oncogene       Date:  2000-08-17       Impact factor: 9.867

7.  Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.

Authors:  J A Kraus; J Felsberg; J C Tonn; G Reifenberger; T Pietsch
Journal:  Neuropathol Appl Neurobiol       Date:  2002-08       Impact factor: 8.090

8.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

9.  Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics.

Authors:  J Barwell; L Pangon; S Hodgson; A Georgiou; I Kesterton; T Slade; M Taylor; S J Payne; H Brinkman; J Smythe; N J Sebire; E Solomon; Z Docherty; R Camplejohn; T Homfray; J R Morris
Journal:  J Med Genet       Date:  2007-05-04       Impact factor: 6.318

10.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Authors:  Johanne Geary; Peter Sasieni; Richard Houlston; Louise Izatt; Ros Eeles; Stewart J Payne; Samantha Fisher; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-10-16       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.